IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
37.65
+1.48 (4.09%)
Jul 2, 2026, 4:00 PM EDT - Market closed
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $3.58 billion as of July 2, 2026. Its market cap has increased by 86.47% in one year.
Market Cap
3.58B
Enterprise Value
2.64B
1-Year Change
86.47%
Ranking
Category
Stock Price
$37.65
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $3.58B, an increase of 1,560.68%. That is a compound annual growth rate of 48.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 3.58B | 18.12% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.04B |
| Catalyst Pharmaceuticals | 3.85B |
| Arcus Biosciences | 3.81B |
| Dyne Therapeutics | 3.81B |
| Structure Therapeutics | 3.80B |
| Parabilis Medicines | 3.77B |
| Enliven Therapeutics | 3.48B |
| Beam Therapeutics | 3.46B |